Importantly from a therapeutic perspective, pharmacological or gene‐based interventions aimed at modulating MTCH2 activity could offer promising strategies for treating metabolic disorders such as obesity and insulin resistance. This evidence concerns the gene MTCH2 and Other metabolic disease.